Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent...

Area of Science:

• Neuroscience
• Psychopharmacology
• Addiction Medicine

Background:

• Long-term, high-dose methamphetamine (METH) use leads to neurocognitive deficits.
• Impaired neurocognition is linked to poorer treatment outcomes in substance dependence.
• This study addresses a critical, under-researched area concerning METH users.

Purpose of the Study:

• To investigate if varenicline enhances cognitive functions in METH-dependent individuals.
• Specifically examining effects on attention, information processing speed, episodic memory, and working memory.
• Assessing varenicline's efficacy in non-treatment-seeking METH-dependent participants.

Main Methods:

• A randomized, placebo-controlled trial involving 26 METH-dependent participants.
• Participants received oral varenicline (up to 1 mg) or placebo over 5 days in inpatient phases.
• Cognitive performance was assessed using tests measuring reaction time, memory, and attention.

Main Results:

• Varenicline significantly improved reaction time on the n-back task for visual stimuli.
• A trend towards improved reaction time for auditory stimuli was observed.
• Cognitive benefits were more pronounced in participants with slower baseline reaction times.

Conclusions:

• Varenicline shows potential for improving information processing speed in METH-dependent individuals.
• Further research with larger samples, longer durations, and higher doses is warranted.
• Varenicline did not significantly impact working memory or episodic memory in this study.